Kintara Therapeutics announces record date for CVR issuance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 14 2024
0mins
Kintara Therapeutics Merger Announcement: Kintara Therapeutics has set October 17 as the record date for issuing Contingent Value Rights (CVRs) to its stockholders, linked to a merger with TuHURA Biosciences, which is expected to close on October 18.
Details of CVRs and Stock Split: Stockholders will receive one CVR per share, entitling them to a total of 53,897,125 shares of common stock upon achieving specific milestones, with a reverse stock split at a ratio of 1-for-35 occurring just before the merger's completion.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
